- Home
- ARQT vs HGV Comparison
ARQT vs HGV Comparison
Compare ARQT & HGV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARQT | HGV |
|---|---|---|
| Founded | 2016 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.3B |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ARQT | HGV |
|---|---|---|
| Price | $20.44 | $48.52 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 8 |
| Target Price | $34.00 | ★ $52.13 |
| AVG Volume (30 Days) | ★ 1.8M | 747.9K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 88.79 | ★ 97.78 |
| EPS | N/A | ★ 0.79 |
| Revenue | $376,072,000.00 | ★ $5,047,000,000.00 |
| Revenue This Year | $34.85 | $25.30 |
| Revenue Next Year | $29.39 | $1.98 |
| P/E Ratio | ★ N/A | $58.58 |
| Revenue Growth | ★ 91.34 | 1.33 |
| 52 Week Low | $12.72 | $36.79 |
| 52 Week High | $31.77 | $52.08 |
Technical Indicators
Market Signals| Indicator | ARQT | HGV |
|---|---|---|
| Relative Strength Index (RSI) | 39.63 | 59.18 |
| Support Level | $19.60 | $42.20 |
| Resistance Level | $24.56 | $49.59 |
| Average True Range (ATR) | 1.27 | 1.81 |
| MACD | -0.20 | -0.04 |
| Stochastic Oscillator | 23.32 | 76.98 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
About HGV Hilton Grand Vacations Inc.
Hilton Grand Vacations Inc is a timeshare company engaged in developing, marketing, selling, managing, and operating timeshare resorts and timeshare plans under the Hilton Grand Vacations brand. The company operates in two segments: Real estate sales and financing, and Resort operations and club management. The Real estate sales and financing segment generates revenue from VOI sales and consumer financing, including interest income from loans to members. The Resort operations and club management segment generates revenue from resort management services, club membership fees, and rental of available inventory. The majority of the company's revenue is earned through the Real estate sales and financing segment.